Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christina Baik
Fred Hutch/University of Washington Cancer Consortium
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Bozeman Deaconess Hospital
Bozeman, Montana, United States
- Kadlec Clinic Hematology and Oncology
Kennewick, Washington, United States
- Skagit Valley Hospital
Mount Vernon, Washington, United States
- Olympic Medical Center
Port Angeles, Washington, United States
- Group Health Cooperative
Redmond, Washington, United States
- Fred Hutch/university of Washington Cancer Consortium
Seattle, Washington, United States
- Spokane Valley Cancer Center-Mission
Spokane, Washington, United States
- Multicare Health System
Tacoma, Washington, United States
- Wenatchee Valley Hospital and Clinics
Wenatchee, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Dec 2012
- Primary completion
- 24 Oct 2017
- Completion
- 29 Apr 2019
- Last update posted
- 16 Jul 2021
- Registered enrollment
- 26
- Registry id
- NCT01620190
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.